Perrigo has finalized its acquisition of Elan Corp., Perrigo said Wednesday.
The Irish High Court has approved Perrigo's pending acquisition of Irish drug maker Elan, the companies said Friday.
The shareholders of Elan Corp. approved the acquisition of the company by Perrigo Co. at two special meetings.
U.S.-based drug maker Perrigo Co. will buy Ireland's Elan Corp. for $8.6 billion, the companies said.
Irish drug maker Elan Corp. said Friday it was looking to sell itself off to a New York-based company that invests in drug royalties after rejecting a previous offer.
Irish drug maker Elan is paying about $380 million to buy two drug makers, the company said.
A privately owned drug maker in New York is offering $6.5 billion for Irish drug maker Elan Corp., but hasn't heard back from it, according to published reports.
Elan will sell the rights to its drug for multiple sclerosis to partnering company Biogen Idec for $3.25 billion plus royalties, the Irish drug maker said.
Alkermes will buy Irish drug maker Elan’s drug formulation and manufacturing business for $960 million, the two companies said Monday.
Irish biotech company Elan and German drug maker Boehringer Ingelheim will collaborate to develop and manufacture antibody-based medicines.